You have 9 free searches left this month | for more free features.

anti-VEGF injections

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Retinal Telangiectasis, Coats Disease Trial in France (Anti-VEGF injections of bevacizumab, Laser)

Recruiting
  • Retinal Telangiectasis
  • Coats Disease
  • Anti-VEGF injections of bevacizumab
  • Laser
  • Cergy-Pontoise, France
  • +4 more
Dec 17, 2021

Automated Optical Coherence Tomography Image Enrichment With

Active, not recruiting
  • Neovascular Age-Related Macular Degeneration
  • Hamilton, Ontario, Canada
  • +16 more
Aug 8, 2022

Reading Speed Improvements in Wet-AMD Patients After Ranibizumab

Completed
  • Ophthalmopathy
  • Wet Macular Degeneration
    • (no location specified)
    Jul 20, 2021

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Saint Petersburg (Dextenza

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • +2 more
    • Dextenza 0.4Mg Ophthalmic Insert
    • Prednisolone Acetate
    • Saint Petersburg, Florida
      Retina Vitreous Associates of Florida
    Mar 10, 2021

    Following Intensive Anti-VEGF Therapy in Wet AMD

    Completed
    • Age-Related Macular Degeneration
    • Budapest, Hungary
    • +1 more
    Dec 28, 2022

    Eye Diseases, Injection Complication, Intraocular Pressure Trial in Athens (Brinzolamide-brimonidine Fixed Combination)

    Completed
    • Eye Diseases
    • +2 more
    • Brinzolamide-brimonidine Fixed Combination
    • Athens, Ambelokipi, Greece
      "Elpis" General Hospital
    Aug 20, 2020

    Diabetic Macular Edema, Pars Plana Vitrectomy, Conbercept Trial in Tianjin (Vitrectomy combined with ILM peeling, Conbercept

    Not yet recruiting
    • Diabetic Macular Edema
    • +2 more
    • Vitrectomy combined with ILM peeling
    • Conbercept intravitreal injection
    • Tianjin, Tianjin, China
      Tianjin medical university eye hosipital
    Feb 14, 2023

    Adult Diabetic Macular Edema and Suboptimal Response to

    Not yet recruiting
    • Diabetic Macular Edema
      • (no location specified)
      Jul 31, 2023

      Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

      Recruiting
      • Macular Edema Due to Type 2 Diabetes Mellitus
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital, School of Medicine, Zhejiang Univers
      Feb 26, 2023

      Neovascular Age-related Macular Degeneration Trial in United States (CLS-AX, Anti-VEGF)

      Completed
      • Neovascular Age-related Macular Degeneration
      • Phoenix, Arizona
      • +10 more
      Dec 1, 2022

      Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

      Recruiting
      • Neovascular Age-related Macular Degeneration
      • ADVM-022
      • Phoenix, Arizona
      • +4 more
      Sep 8, 2022

      Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

      Completed
      • Wet Age-related Macular Degeneration
      • Intravitreal anti-VEGF
      • +2 more
      • Boston, Massachusetts
      • +1 more
      May 24, 2022

      Macular Degeneration Trial (Zimura, Avastin, Lucentis)

      Completed
      • Macular Degeneration
      • (no location specified)
      Oct 4, 2022

      Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

      Not yet recruiting
      • Lung Adenocarcinoma
      • +3 more
      • Serplulimab and Bevacizumab injection
      • (no location specified)
      Dec 21, 2022

      Macular Degeneration, Wet, Metamorphopsia Trial

      Recruiting
      • Macular Degeneration, Wet
      • Metamorphopsia
        • Cuneo, Piedmont, Italy
          Ospedale Santa Croce
        Sep 20, 2022

        Focal Laser Single Intravitreal Ranibizumab Retinal Artery

        Completed
        • Retinal Artery Macroaneurysm
        • Dual focal laser and intravitreal Ranibizumab injection
        • Cairo, Egypt
          Kasr alainy faculty of medicine
        Jan 29, 2023

        s in Wet AMD in Active Smokers

        Completed
        • Wet Age-related Macular Degeneration
        • Medical Data extraction
        • Brussels, Belgium
          CHU Brugmann
        Mar 7, 2022

        Proliferative Diabetic Retinopathy, Vitreous Hemorrhage, Tractional Retinal Detachment Trial in Monastir (Bevacizumab Injection

        Recruiting
        • Proliferative Diabetic Retinopathy
        • +2 more
        • Bevacizumab Injection [Avastin]
        • Peripheral Retinal Cryoapplication
        • Monastir, Tunisia
          Fattouma Bourguiba University Hospital - Ophthalmology Departmen
        Aug 22, 2022

        NSCLC Trial (PM8002, Placebo, Carboplatin)

        Not yet recruiting
        • NSCLC
        • (no location specified)
        Feb 23, 2023

        SCLC, Extensive Stage Trial in Shanghai (AK112, Etoposide, Carboplatin)

        Recruiting
        • SCLC, Extensive Stage
        • Shanghai, Shanghai, China
          Shun Lu
        Oct 12, 2022

        Ocular Adverse Events in Neovascular Agerelated Macular

        Completed
        • Age-related Macular Degeneration (AMD)
        • Aflibercept
        • +2 more
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021

        Ocular Adverse Events in Neovascular Age-related Macular

        Completed
        • Age-related Macular Degeneration (AMD)
        • Aflibercept
        • +2 more
        • East Hanover, New Jersey
          Novartis Investigative Site
        Dec 15, 2021

        Real-Life Study in Diabetic Macular Edema

        Completed
        • Diabetic Macular Edema
        • Retrospective study
        • Kocaeli, None Selected, Turkey
        • +9 more
        Jul 22, 2022

        Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial

        Completed
        • Neovascular Age-related Macular Degeneration
        • Wet Macular Degeneration
        • Palo Alto, California
        • +4 more
        Jun 5, 2020

        Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

        Completed
        • Advanced Cancer
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Nov 21, 2022